Oh Y - Search Results

1

Oh Y, Osato MS, Han X, Bennett G, Hong WK. Oh Y, et al. J Appl Microbiol. 2002;93(6):1083-8. doi: 10.1046/j.1365-2672.2002.01779.x. J Appl Microbiol. 2002. PMID: 12452966 Free article.

2

Lactobacillus plantarum for oral peptide delivery.

Oh Y, Varmanen P, Han XY, Bennett G, Xu Z, Lu T, Palva A. Oh Y, et al. Oral Microbiol Immunol. 2007 Apr;22(2):140-4. doi: 10.1111/j.1399-302X.2007.00338.x. Oral Microbiol Immunol. 2007. PMID: 17311639

3

Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.

Kim SK, Su LK, Oh Y, Kemp BL, Hong WK, Mao L. Kim SK, et al. Among authors: oh y. Oncogene. 1998 Jan 8;16(1):89-93. doi: 10.1038/sj.onc.1201512. Oncogene. 1998. PMID: 9467947

4

TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.

Oh Y, Proctor ML, Fan YH, Su LK, Hong WK, Fong KM, Sekido YS, Gazdar AF, Minna JD, Mao L. Oh Y, et al. Oncogene. 1998 Sep 3;17(9):1141-8. doi: 10.1038/sj.onc.1202029. Oncogene. 1998. PMID: 9764824

5

A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.

Wang L, Rodriguez M, Kim ES, Xu Y, Bekele N, El-Naggar AK, Hong WK, Mao L, Oh YW. Wang L, et al. Among authors: oh yw. Int J Oncol. 2004 Oct;25(4):993-9. Int J Oncol. 2004. PMID: 15375549

6

Phenotypic diversity of the lung vasculature in experimental models of metastases.

Oh Y, Mohiuddin I, Sun Y, Putnam JB Jr, Hong WK, Arap W, Pasqualini R. Oh Y, et al. Chest. 2005 Dec;128(6 Suppl):596S-600S. doi: 10.1378/chest.128.6_suppl.596S. Chest. 2005. PMID: 16373855 Review.

7

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.

Zinner RG, Fossella FV, Gladish GW, Glisson BS, Blumenschein GR Jr, Papadimitrakopoulou VA, Pisters KM, Kim ES, Oh YW, Peeples BO, Ye Z, Curiel RE, Obasaju CK, Hong WK, Herbst RS. Zinner RG, et al. Cancer. 2005 Dec 1;104(11):2449-56. doi: 10.1002/cncr.21480. Cancer. 2005. PMID: 16258975 Free article. Clinical Trial.

8

Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.

William WN Jr, Zinner RG, Karp DD, Oh YW, Glisson BS, Phan SC, Stewart DJ. William WN Jr, et al. J Thorac Oncol. 2007 Aug;2(8):745-50. doi: 10.1097/JTO.0b013e31811f4719. J Thorac Oncol. 2007. PMID: 17762342 Free article. Clinical Trial.

9

Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.

Oh SH, Lee OH, Schroeder CP, Oh YW, Ke S, Cha HJ, Park RW, Onn A, Herbst RS, Li C, Lee HY. Oh SH, et al. Mol Cancer Ther. 2006 Nov;5(11):2685-95. doi: 10.1158/1535-7163.MCT-06-0142. Mol Cancer Ther. 2006. PMID: 17121915

10

Biomarkers in head and neck carcinoma.

Oh Y, Mao L. Oh Y, et al. Curr Opin Oncol. 1997 May;9(3):247-56. doi: 10.1097/00001622-199709030-00006. Curr Opin Oncol. 1997. PMID: 9229147 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,502 results

Search Page